Investigation of 17-ketosteriod excretion in mastopathia and premenopausal breast cancer
- PMID: 129041
Investigation of 17-ketosteriod excretion in mastopathia and premenopausal breast cancer
Abstract
Measurement of the excretion of total 17-ketosteroids, androsterone, etiocholanolone, and dehydroepiandrosterone demonstrate in contrast to the well known age dependency of normal women in cases of both mastopathia and breast cancer the following results: 1. the age dependence of the 17-ketosteriod excretion is not marked; 2. the total 17-ketosteroid excretion is lower than that of normal controls, 3. the values of the etiocholanolone excretions and that of the dehydroepiandrosterone excretions are similarly lower.
Similar articles
-
The excretion of 17-ketosteroids in patients suffering from mastopathia fibrocystica and mammary carcinomas.Arch Geschwulstforsch. 1975;45(7):648-57. Arch Geschwulstforsch. 1975. PMID: 132149
-
Urinary 17-ketosteroid fractions in young patients with breast cancer.Endocrinologie. 1978 Apr-Jun;16(2):135-7. Endocrinologie. 1978. PMID: 150018
-
Urinary excretion of 17-ketosteroids in patients suffering from mammary cancer.Arch Geschwulstforsch. 1975;45(5):457-63. Arch Geschwulstforsch. 1975. PMID: 129042
-
The role of hormones in the etiology of human breast cancer.Cancer. 1977 Jun;39(6 Suppl):2716-26. doi: 10.1002/1097-0142(197706)39:6<2716::aid-cncr2820390659>3.0.co;2-3. Cancer. 1977. PMID: 326377 Review. No abstract available.
-
The metabolism of steroid hormones in breast cancer: a reappraisal.Curr Top Mol Endocrinol. 1976;4:36-50. doi: 10.1007/978-1-4684-2601-4_4. Curr Top Mol Endocrinol. 1976. PMID: 800358 Review. No abstract available.